INFINIUM PHARMACHEM LTD (INFINIUM) reported revenue of ₹71.00 Cr and net profit of ₹4.00 Cr for the quarter ended 2024-09-30. Figures are parsed from the company's filed results.
The statements below are read from INFINIUM PHARMACHEM LTD’s filed results, 4 filed quarters and 7 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: H2 FY25-26 · filed Jul 18, 2026 · audited
This company files half-yearly statements with the exchange — each column is a six-month period; discrete quarterly figures are not published.
| ₹ Cr | H1 FY24Sep 2023 | H1 FY25Sep 2024 | H1 FY26Sep 2025 | H2 FY26Mar 2026Latest | YoYlatest |
|---|---|---|---|---|---|
| Sales | 61.5 | 83.0 | 84.1 | 106 | — |
| 51.2 | 74.5 | 73.6 | 94.5 | — | |
| Operating profit | 10.3 | 8.47 | 10.4 | 11.1 | — |
| OPM % | 16.7% | 10.2% | 12.4% | 10.5% | — |
| Other income | 0.34 | 1.08 | 1.00 | 1.14 | — |
| Interest | 1.06 | 1.57 | 1.56 | 1.24 | — |
| Depreciation | 1.25 | 1.51 | 1.55 | 1.51 | — |
| Profit before tax | 8.29 | 6.47 | 8.33 | 9.51 | — |
| Tax % | 24.3% | 25.3% | 21.7% | 19.3% | — |
| Net profit | 6.28 | 4.83 | 6.52 | 7.68 | — |
| EPS (₹) | 4.46 | 3.17 | 3.59 | 4.20 | — |
